£50 million funding has been secured for a major life sciences scheme in Norwich, marking a significant investment in the region’s research and innovation sector.

The new funding forms part of a broader initiative to attract substantial public and private investment into Norwich’s growing life sciences community. The scheme will strengthen Norwich’s reputation as a centre of excellence in bioscience by delivering new laboratories, offices, and advanced research facilities to support high-growth companies and pioneering scientific work.

The £50 million investment will underpin the expansion of infrastructure at the Norwich Research Park, one of Europe’s leading clusters for life and environmental sciences. The project will provide state-of-the-art facilities for research-led businesses, including spinouts and scale-ups, helping to accelerate the development and application of new scientific discoveries.

This initiative complements a wider funding landscape at the Norwich Research Park, which includes long-term commitments from public sector organisations such as UK Research and Innovation (UKRI) and the Biotechnology and Biological Sciences Research Council (BBSRC), alongside leading private partners. Collectively, related projects are expected to contribute hundreds of millions of pounds in additional investment through to 2030.

The scheme is expected to drive rapid campus growth in 2025, attract leading bioscience companies, and create new high-technology jobs for the region. It will also support ventures developing solutions in agribiotech, food biotech, MedTech, climate, and biodiversity, aligning with Norwich Research Park’s wider vision to be a global hub for innovation and collaboration.

With strong government and investor backing, the scheme will accelerate the commercialisation of advanced bioscience, providing long-term benefits for the Norwich region and contributing to the strength and competitiveness of the UK’s science economy.